Assertio (NASDAQ:ASRT) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of Assertio (NASDAQ:ASRT) from a buy rating to a hold rating in a report released on Monday morning.

Separately, HC Wainwright reiterated a “buy” rating and set a $4.00 price objective on shares of Assertio in a report on Monday, December 16th.

Assertio Stock Performance

NASDAQ ASRT opened at $0.71 on Monday. The business’s 50-day moving average price is $0.80 and its 200 day moving average price is $0.96. The company has a current ratio of 2.01, a quick ratio of 1.57 and a debt-to-equity ratio of 0.30. Assertio has a twelve month low of $0.68 and a twelve month high of $1.80. The company has a market capitalization of $67.99 million, a PE ratio of -0.97, a price-to-earnings-growth ratio of 3.25 and a beta of 0.81.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in ASRT. XTX Topco Ltd acquired a new position in Assertio during the third quarter valued at approximately $203,000. GSA Capital Partners LLP purchased a new stake in Assertio during the 3rd quarter worth $177,000. CM Management LLC increased its holdings in Assertio by 23.1% in the 4th quarter. CM Management LLC now owns 400,000 shares of the company’s stock valued at $348,000 after purchasing an additional 75,000 shares in the last quarter. Marshall Wace LLP purchased a new position in Assertio in the fourth quarter valued at about $64,000. Finally, Wealthfront Advisers LLC purchased a new position in Assertio in the fourth quarter valued at about $53,000. 48.96% of the stock is owned by hedge funds and other institutional investors.

Assertio Company Profile

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.